Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 25, 2021 at 04:22 am EDT
Share
Guangzhou Wondfo Biotech Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 2,507.11 million compared to CNY 2,173.09 million a year ago. Revenue was CNY 2,507.11 million compared to CNY 2,173.09 million a year ago. Net income was CNY 627.24 million compared to CNY 565.94 million a year ago. Basic earnings per share from continuing operations was CNY 1.42 compared to CNY 1.28 a year ago. Diluted earnings per share from continuing operations was CNY 1.42 compared to CNY 1.28 a year ago.
GUANGZHOU WONDFO BIOTECH CO., LTD. is a China-based company principally engaged in research, manufacture and sales of point-of-care testing (POCT) reagents, POCT instrument and related products. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The Company's products are used in POCT, clinical test, field test and personal health management, among others.